| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 11,82 | 59,08 | Association of the Cluster of Genetic Risk Factors in Loci Related to Glycoxidation with Diabetic Nephropathy in Type 2 Diabetes Mellitus
|
| 9,78 | 58,70 | Genetic variability in the pentose phosphate cycle enzymes as a treatment-independent modifier of hyperglycemia toxicity in diabetic nephropathy
|
| 0,31 | 2,81 | Identifikace genetických rizikových faktor diabetické nefropatie u T2DM v genech pro EDN1, LTA, RAGE a NOS3 pomocí multilokusové analýzy
|
| 13,53 | 54,11 | Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
|
| 26,31 | 78,93 | Increased plasma levels of sRAGE in patients with diabetic nephropathy
|
| 1,04 | 5,20 | Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene
|
| 19,15 | 191,53 | Thiamine Status and Genetic Variability in the Pentose Phosphate Cycle Enzymes as Risk Factors for Diabetic Nephropathy
|
| 7,18 | 64,58 | Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach
|
| 10,82 | 54,11 | Haplotype-based association study between the region of 6p chromosome spanning the AGER - TNFA - LTA - NFKBIL1 - BAT1 and diabetic nephropathy
|
| 1,40 | 5,62 | Diabetická nefropatie, solubilní RAGE a genetická variabilita AGER genu
|
| 1,87 | 5,62 | Diabetická nefropatie- renální funce a hladina sRAGE, genet. variabilita AGER genu
|
| 0,00 | 0,00 | Relationship between circulating levels of soluble RAGE (sRAGE) and genetic variability in the AGER gene in subjects with diabetic nephropathy
|
Back
(c) Michal Bulant, 2011